Literature DB >> 30273227

Dysregulation of the Inflammatory Mediators in the Multifidus Muscle After Spontaneous Intervertebral Disc Degeneration SPARC-null Mice is Ameliorated by Physical Activity.

Gregory James1, Magali Millecamps2, Laura S Stone2, Paul W Hodges1.   

Abstract

STUDY
DESIGN: A longitudinal case-control animal model.
OBJECTIVE: The aim of this study was to investigate the inflammatory pathways active in the multifidus muscle after spontaneous intervertebral disc degeneration (IDD), and whether these IDD-related muscle changes can be ameliorated by exercise. SUMMARY OF BACKGROUND DATA: A pro-inflammatory response is present in the multifidus muscle after an intervertebral disc lesion and has been proposed to drive the structural alterations present during low back pain. However, it is not known whether spontaneous IDD produces an inflammatory response. Furthermore, exercise/physical activity produces a strong anti-inflammatory response, but its effectiveness in ameliorating inflammation in the multifidus is unknown. We assessed the inflammatory profile of the multifidus and the effectiveness of physical activity as a treatment using an animal model of spontaneous model of IDD.
METHODS: Wild-type and SPARC null mice that were sedentary or housed with a running wheel were used in this study. Multifidus muscle segments were harvested from L2-L6 from the mice at 9 months of age after they had undergone a magnetic resonance imaging (MRI) scan to determine levels with IDD. The inflammatory profile of the multifidus was examined using quantitative polymerase chain reaction (PCR) assays.
RESULTS: Spontaneous IDD in the SPARC-null mice caused a dysregulation of interleukin (IL)-1β, IL6, transforming growth factor-beta (TGFβ1), and adiponectin expression. More specifically, the proximity and degree of IDD was related to levels of IL-1β expression. Physical activity reduced the pro-inflammatory response to IDD in the multifidus. IL-1β, tumor necrosis factor (TNF), IL-10, adiponectin, and leptin levels were lower in the physically active group.
CONCLUSION: These results reveal that spontaneous IDD causes dysregulation of the inflammatory pathways active in the multifidus muscle. These alterations were related to the severity of IDD and were prevented by physical activity. LEVEL OF EVIDENCE: N/A.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30273227     DOI: 10.1097/BRS.0000000000002656

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  17 in total

1.  Fat infiltration in the multifidus muscle is related to inflammatory cytokine expression in the muscle and epidural adipose tissue in individuals undergoing surgery for intervertebral disc herniation.

Authors:  Greg James; Xiaolong Chen; Ashish Diwan; Paul W Hodges
Journal:  Eur Spine J       Date:  2020-06-27       Impact factor: 3.134

Review 2.  Paraspinal muscle imaging measurements for common spinal disorders: review and consensus-based recommendations from the ISSLS degenerative spinal phenotypes group.

Authors:  Paul W Hodges; Jeannie F Bailey; Maryse Fortin; Michele C Battié
Journal:  Eur Spine J       Date:  2021-09-20       Impact factor: 3.134

3.  Correlation between the fatty infiltration of paraspinal muscles and disc degeneration and the underlying mechanism.

Authors:  Liqiang Shi; Bin Yan; Yucheng Jiao; Zhe Chen; Yuehuan Zheng; Yazhou Lin; Peng Cao
Journal:  BMC Musculoskelet Disord       Date:  2022-05-30       Impact factor: 2.562

4.  Muscle spindles of the multifidus muscle undergo structural change after intervertebral disc degeneration.

Authors:  Gregory James; Carla Stecco; Linda Blomster; Leanne Hall; Annina B Schmid; Cindy C Shu; Christopher B Little; James Melrose; Paul W Hodges
Journal:  Eur Spine J       Date:  2022-05-27       Impact factor: 2.721

Review 5.  Intervertebral disc degeneration and regeneration: a motion segment perspective.

Authors:  B Ashinsky; H E Smith; R L Mauck; S E Gullbrand
Journal:  Eur Cell Mater       Date:  2021-03-24       Impact factor: 3.942

Review 6.  Research Progress on the Mechanism of Lumbarmultifidus Injury and Degeneration.

Authors:  Xianzheng Wang; Rui Jia; Jiaqi Li; Yibo Zhu; Huanan Liu; Weijian Wang; Yapeng Sun; Fei Zhang; Lei Guo; Wei Zhang
Journal:  Oxid Med Cell Longev       Date:  2021-02-26       Impact factor: 6.543

7.  Interleukin-8 as a therapeutic target for chronic low back pain: Upregulation in human cerebrospinal fluid and pre-clinical validation with chronic reparixin in the SPARC-null mouse model.

Authors:  Emerson Krock; Magali Millecamps; Kathleen M Anderson; Akanksha Srivastava; Troy E Reihsen; Pawan Hari; Yue Ran Sun; Seon Ho Jang; George L Wilcox; Kumar G Belani; David S Beebe; Jean Ouellet; Manuel R Pinto; Lois J Kehl; Lisbet Haglund; Laura S Stone
Journal:  EBioMedicine       Date:  2019-04-30       Impact factor: 8.143

8.  Forced treadmill running reduces systemic inflammation yet worsens upper limb discomfort in a rat model of work-related musculoskeletal disorders.

Authors:  Tianqi Tenchi Gao Smith; Ann E Barr-Gillespie; David M Klyne; Michelle Y Harris; Mamta Amin; Ryan W Paul; Geneva E Cruz; Huaqing Zhao; Sean Gallagher; Mary F Barbe
Journal:  BMC Musculoskelet Disord       Date:  2020-01-30       Impact factor: 2.362

9.  Fascial tissue research in sports medicine: from molecules to tissue adaptation, injury and diagnostics: consensus statement.

Authors:  Robert Schleip; Paul William Hodges; Martina Zügel; Constantinos N Maganaris; Jan Wilke; Karin Jurkat-Rott; Werner Klingler; Scott C Wearing; Thomas Findley; Mary F Barbe; Jürgen Michael Steinacker; Andry Vleeming; Wilhelm Bloch
Journal:  Br J Sports Med       Date:  2018-08-02       Impact factor: 13.800

10.  Regional differences between superficial and deep lumbar multifidus in patients with chronic lumbar spine pathology.

Authors:  Jennifer Padwal; David B Berry; James C Hubbard; Vinko Zlomislic; R Todd Allen; Steven R Garfin; Samuel R Ward; Bahar Shahidi
Journal:  BMC Musculoskelet Disord       Date:  2020-11-20       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.